[The results of attack polychemotherapy in broncho-pleuro-pulmonary cancer. Phytohemagglutinin in the prevention and treatment of hematologic complications of antimitotics].
D000741:Anemia, Aplastic / Q000139:chemically induced*; D000903:Antibiotics, Antineoplastic / Q000009:adverse effects; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001389:Azirines / Q000009:adverse effects; D001984:Bronchial Neoplasms / Q000188:drug therapy*; D004357:Drug Synergism; D005472:Fluorouracil / Q000009:adverse effects; D006801:Humans; D006834:Hydrazines / Q000009:adverse effects; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D037102:Lectins / Q000627:therapeutic use*; D008175:Lung Neoplasms / Q000188:drug therapy*; D008466:Mechlorethamine / Q000009:adverse effects; D015122:Mercaptopurine / Q000009:adverse effects; D008727:Methotrexate / Q000009:adverse effects; D010997:Pleural Neoplasms / Q000188:drug therapy*; D014747:Vinblastine / Q000009:adverse effects
D000903:Antibiotics, Antineoplastic; D000970:Antineoplastic Agents; D001389:Azirines; D006834:Hydrazines; D037102:Lectins; D008466:Mechlorethamine; D014747:Vinblastine; D015122:Mercaptopurine; D005472:Fluorouracil; D008727:Methotrexate
Les résultats de la polychimiothérapie d'attaque des cancers broncho-pleuro-pulmonaires. La phytohémagglutinine dans la prévention et le traitement des accidents hématologiques des antimitotiques.